logo-loader
HealthCannabis
viewCanntab Therapeutics Ltd

Full interview: Canntab Therapeutics sign supply and distribution agreement with Exactus in U.S.

Canntab Therapeutics (CSE: PILL-OTCQBCTABF) CFO Richard Goldstein joined Steve Darling on Skype with news the company has signed a transformative deal with Exactus in the United States. 

Goldstein talks about the many layers of this deal and the revenue they feel they can generate on many levels. Goldstein also shared the timing for getting the Florida operations up and running. 

 
 

Quick facts: Canntab Therapeutics Ltd

Price: 0.425 CAD

CSE:PILL
Market: CSE
Market Cap: $10.76 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canntab Therapeutics Ltd named herein, including the promotion by the Company of Canntab Therapeutics Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Exactus clinches two supply agreements

Exactus Inc (OTCMKTS:EXDI) CEO Emiliano Aloi tells Proactive it has entered into a supply and distribution agreement with Ceed2Med, as well as supplying hemp to Canntab Therapeutics Limited (CSE:PILL) (OTCMKTS:CTABF). Aloi says its an exciting venture and expects to push its products with...

1 week, 3 days ago

2 min read